Fusion Pharm Stock Market Value
| FSPM Stock | USD 0.0001 0.00 0.00% |
| Symbol | Fusion |
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion Pharm. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.133 | Return On Assets (1.38) |
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fusion Pharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fusion Pharm's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fusion Pharm.
| 01/07/2025 |
| 02/06/2025 |
If you would invest 0.00 in Fusion Pharm on January 7, 2025 and sell it all today you would earn a total of 0.00 from holding Fusion Pharm or generate 0.0% return on investment in Fusion Pharm over 30 days. FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in th... More
Fusion Pharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fusion Pharm's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fusion Pharm upside and downside potential and time the market with a certain degree of confidence.
Fusion Pharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fusion Pharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fusion Pharm's standard deviation. In reality, there are many statistical measures that can use Fusion Pharm historical prices to predict the future Fusion Pharm's volatility.Fusion Pharm Backtested Returns
We have found three technical indicators for Fusion Pharm, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Fusion Pharm are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Fusion Pharm has no correlation between past and present. Overlapping area represents the amount of predictability between Fusion Pharm time series from 7th of January 2025 to 22nd of January 2025 and 22nd of January 2025 to 6th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fusion Pharm price movement. The serial correlation of 0.0 indicates that just 0.0% of current Fusion Pharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Fusion Pharm lagged returns against current returns
Autocorrelation, which is Fusion Pharm stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Fusion Pharm's stock expected returns. We can calculate the autocorrelation of Fusion Pharm returns to help us make a trade decision. For example, suppose you find that Fusion Pharm has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Fusion Pharm regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Fusion Pharm stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Fusion Pharm stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Fusion Pharm stock over time.
Current vs Lagged Prices |
| Timeline |
Fusion Pharm Lagged Returns
When evaluating Fusion Pharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Fusion Pharm stock have on its future price. Fusion Pharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Fusion Pharm autocorrelation shows the relationship between Fusion Pharm stock current value and its past values and can show if there is a momentum factor associated with investing in Fusion Pharm.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Fusion Pharm Correlation, Fusion Pharm Volatility and Fusion Pharm Alpha and Beta module to complement your research on Fusion Pharm. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Fusion Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.